Insider Selling: Sabra Healthcare REIT (NASDAQ:SBRA) Director Sells $209,800.00 in Stock

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Director Michael Foster sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $20.98, for a total value of $209,800.00. Following the sale, the director directly owned 72,834 shares of the company’s stock, valued at approximately $1,528,057.32. This trade represents a 12.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Sabra Healthcare REIT Trading Down 1.1%

Shares of NASDAQ SBRA traded down $0.23 during mid-day trading on Thursday, hitting $20.73. The stock had a trading volume of 602,138 shares, compared to its average volume of 2,682,900. The firm has a market cap of $5.43 billion, a P/E ratio of 74.06, a price-to-earnings-growth ratio of 1.86 and a beta of 0.68. The business has a 50 day moving average price of $19.90 and a two-hundred day moving average price of $20.03. Sabra Healthcare REIT, Inc. has a 1 year low of $17.53 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The business had revenue of $249.57 million during the quarter, compared to analysts’ expectations of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. Sabra Healthcare REIT’s quarterly revenue was up 31.4% compared to the same quarter last year. During the same period last year, the firm posted $0.38 EPS. On average, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s payout ratio is currently 428.57%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently modified their holdings of SBRA. Versant Capital Management Inc increased its position in Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares in the last quarter. Root Financial Partners LLC purchased a new position in shares of Sabra Healthcare REIT during the third quarter valued at approximately $34,000. Heritage Family Offices LLP purchased a new position in Sabra Healthcare REIT during the 3rd quarter worth $45,000. Mather Group LLC. grew its stake in shares of Sabra Healthcare REIT by 34,550.0% during the third quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust’s stock worth $55,000 after acquiring an additional 2,764 shares during the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Sabra Healthcare REIT in the second quarter valued at about $61,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several research reports. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Huntington assumed coverage on shares of Sabra Healthcare REIT in a research report on Monday, November 2nd. They issued a “strong-buy” rating for the company. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Wells Fargo & Company dropped their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Finally, Deutsche Bank reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $21.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.